Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Unlocking the therapeutic potential of primary tumor-draining lymph nodes
Jossie Rotman, Bas D. Koster, Ekaterina S. Jordanova, et al.
Cancer Immunology Immunotherapy (2019) Vol. 68, Iss. 10, pp. 1681-1688
Open Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment
Muyue Yang, Jipeng Li, Ping Gu, et al.
Bioactive Materials (2020) Vol. 6, Iss. 7, pp. 1973-1987
Open Access | Times Cited: 548
The Tim-3-Galectin-9 Pathway and Its Regulatory Mechanisms in Human Breast Cancer
Inna M. Yasinska, Svetlana Sakhnevych, Ludmila Pavlova, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 147
Vaccine delivery systems toward lymph nodes
Yingyue Ding, Zhaoting Li, Ana Jaklenec, et al.
Advanced Drug Delivery Reviews (2021) Vol. 179, pp. 113914-113914
Open Access | Times Cited: 123
Albumin nanoparticle containing a PI3Kγ inhibitor and paclitaxel in combination with α-PD1 induces tumor remission of breast cancer in mice
Yudong Song, Luke F. Bugada, Ruiting Li, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 643
Open Access | Times Cited: 77
Tumor draining lymph nodes, immune response, and radiotherapy: Towards a revisal of therapeutic principles
Michael I. Koukourakis, Alexandra Giatromanolaki
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 3, pp. 188704-188704
Closed Access | Times Cited: 46
Hippo-signaling-controlled MHC class I antigen processing and presentation pathway potentiates antitumor immunity
Linyuan Peng, Liang Zhou, Huan Li, et al.
Cell Reports (2024) Vol. 43, Iss. 4, pp. 114003-114003
Open Access | Times Cited: 13
Tumor Cell-associated Exosomes Robustly Elicit Anti-tumor Immune Responses through Modulating Dendritic Cell Vaccines in Lung Tumor
Ce Wang, Xue F. Huang, Yingjuan Wu, et al.
International Journal of Biological Sciences (2020) Vol. 16, Iss. 4, pp. 633-643
Open Access | Times Cited: 66
STING Activator c-di-GMP-Loaded Mesoporous Silica Nanoparticles Enhance Immunotherapy Against Breast Cancer
Yi‐Ping Chen, Li Xu, Tao-Wei Tang, et al.
ACS Applied Materials & Interfaces (2020) Vol. 12, Iss. 51, pp. 56741-56752
Closed Access | Times Cited: 65
Tumor-Associated Extracellular Matrix: How to Be a Potential Aide to Anti-tumor Immunotherapy?
Yingying He, Tao Liu, Shuang Dai, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 56
The aryl hydrocarbon receptor suppresses immunity to oral squamous cell carcinoma through immune checkpoint regulation
Jessica E. Kenison, Zhongyan Wang, Kangkang Yang, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 19
Open Access | Times Cited: 55
Targeting lymph node delivery with nanovaccines for cancer immunotherapy: recent advances and future directions
Yueyi Li, Li Shen, Zedong Jiang, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 18
Leveraging β‐Adrenergic Receptor Signaling Blockade for Improved Cancer Immunotherapy Through Biomimetic Nanovaccine
Chao Yang, Yi He, Fangman Chen, et al.
Small (2023) Vol. 19, Iss. 14
Closed Access | Times Cited: 17
Targeting lymph nodes for enhanced cancer vaccination: From nanotechnology to tissue engineering
Jie Wang, Zongying Zhang, Rongxiang Liang, et al.
Materials Today Bio (2024) Vol. 26, pp. 101068-101068
Open Access | Times Cited: 8
RNAi mediated silencing of STAT3/PD-L1 in tumor-associated immune cells induces robust anti-tumor effects in immunotherapy resistant tumors
Shanthi Ganesh, Min Ju Kim, Jenny Lee, et al.
Molecular Therapy (2024) Vol. 32, Iss. 6, pp. 1895-1916
Open Access | Times Cited: 7
Remodeling of the Lymph Node High Endothelial Venules Reflects Tumor Invasiveness in Breast Cancer and is Associated with Dysregulation of Perivascular Stromal Cells
Tove Bekkhus, Teemu Martikainen, Anna Olofsson, et al.
Cancers (2021) Vol. 13, Iss. 2, pp. 211-211
Open Access | Times Cited: 33
Immunotherapeutic Approaches for the Treatment of HPV-Associated (Pre-)Cancer of the Cervix, Vulva and Penis
Tynisha S. Rafael, Jossie Rotman, Oscar R. Brouwer, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 4, pp. 1101-1101
Open Access | Times Cited: 19
Engineering Targeting Materials for Therapeutic Cancer Vaccines
Priscilla S. Briquez, Sylvie Hauert, Alexandre de Titta, et al.
Frontiers in Bioengineering and Biotechnology (2020) Vol. 8
Open Access | Times Cited: 28
Bronchoscopic intratumoural therapies for non-small cell lung cancer
Andrew DeMaio, Daniel H. Sterman
European Respiratory Review (2020) Vol. 29, Iss. 156, pp. 200028-200028
Open Access | Times Cited: 28
High expression of PD-L1 on conventional dendritic cells in tumour-draining lymph nodes is associated with poor prognosis in oral cancer
H. Eric, Krzysztof Piersiala, Vilma Lagebro, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 9
Open Access | Times Cited: 3
Tumor-specific CXCR6 positive precursor CD8+ T cells mediate tumor control in metastatic melanoma
Yang Song, Ji Chen, Yaqin Zhang, et al.
Cellular Oncology (2025)
Open Access
The role and clinical significance of tumor-draining lymph nodes in tumor progression and immunotherapy
Qian Xu, Jiahui Chu, Qiao Hu, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104745-104745
Closed Access
CD8 + T cells in breast cancer tumors and draining lymph nodes: PD-1 levels, effector functions and prognostic relevance
Carolina Abrate, Fernando P. Canale, Sabrina Bossio, et al.
OncoImmunology (2025) Vol. 14, Iss. 1
Open Access
18F-AraG PET for CD8 Profiling of Tumors and Assessment of Immunomodulation by Chemotherapy
Jelena Levi, Samuel R. Goth, Lyna Huynh, et al.
Journal of Nuclear Medicine (2020) Vol. 62, Iss. 6, pp. 802-807
Open Access | Times Cited: 27
Positron emission tomography molecular imaging to monitor anti-tumor systemic response for immune checkpoint inhibitor therapy
Xiaoqing Xing, Qing Zhao, Jinyun Zhou, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 50, Iss. 6, pp. 1671-1688
Open Access | Times Cited: 8
Immunomodulatory properties of the lymphatic endothelium in the tumor microenvironment
Cristina Viúdez-Pareja, Ewa Kreft, Melissa García‐Caballero
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top